Wanbury gets GMP certificate for Patalganga facility

20 May 2025 Evaluate

Wanbury’s Patalganga manufacturing site has successfully received Good Manufacturing Practices (GMP) certificate from the office of Brazil Health Regulatory Agency (ANVISA). On May 12, the company had received certificate from ANVISA for its Tanuku Site, Andhra Pradesh. 

Brazil Health Regulatory Agency reviewed inspection report of USFDA and other documents of Wanbury Patalganga site. As a result, ANVISA has granted the Good Manufacturing Practices (GMP) certificate for the facility. With this certificate, now both the API manufacturing sites of Wanbury are continued to be compliant per ANVISA' s rules & regulations.

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. 

Wanbury Share Price

232.00 4.85 (2.14%)
01-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.80
Dr. Reddys Lab 1252.40
Cipla 1500.00
Zydus Lifesciences 914.55
Lupin 2106.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×